Trial
NCT05298358
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
Systemic Sclerosis
Intervention
RIC alloBMT w PTCy in refractory SSc
Why stopped
This study was closed due to low accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-04